Literature DB >> 9522209

Current status of CD44 variant isoforms as cancer diagnostic markers.

S Goodison1, D Tarin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9522209     DOI： 10.1046/j.1365-2559.1998.00262.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  3 in total

1.  Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.

Authors:  J M Karjalainen; R H Tammi; M I Tammi; M J Eskelinen; U M Agren; J J Parkkinen; E M Alhava; V M Kosma
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  The CD44 receptor is a molecular predictor of survival in ovarian cancer.

Authors:  L Rodríguez-Rodríguez; I Sancho-Torres; C Mesonero; D G Gibbon; W J Shih; G Zotalis
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

3.  Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface.

Authors:  B Desai; T Ma; J Zhu; M A Chellaiah
Journal:  J Cell Biochem       Date:  2009-09-01       Impact factor: 4.429
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.